Publication | Closed Access

Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo

Combinatorial ChemistryMedicinal ChemistryMedicinePotent Anticancer CompoundsQuinoxaline DerivativesStructure-based DesignAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyDrug Discovery